ArticleOncoimmunology2021

Anti-tumor efficacy of a combination therapy with PD-L1 targeted alpha therapy and adoptive cell transfer of PD-1 deficient melanoma-specific human T-lymphocytes.

L Marotte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.